239 related articles for article (PubMed ID: 8846535)
1. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
2. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
[TBL] [Abstract][Full Text] [Related]
3. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin I-converting enzyme polymorphism on development of post-transplant erythrocytosis in renal graft recipients.
Kedzierska K; Kabat-Koperska J; Safranow K; Domański M; Gołembiewska E; Bober J; Bohatyrewicz R; Ciechanowski K
Clin Transplant; 2008; 22(2):156-61. PubMed ID: 18339134
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of erythrocytosis post renal transplantation.
Razeghi E; Kaboli A; Pezeshki ML; Meysamie AP; Khatami MR; Khashayar P
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):559-63. PubMed ID: 18580013
[TBL] [Abstract][Full Text] [Related]
7. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
8. Erythrocytosis after renal transplantation. A prospective analysis.
Sumrani NB; Daskalakis P; Miles AM; Sarkar S; Markell MS; Hong JH; Friedman EA; Sommer BG
ASAIO J; 1993; 39(1):51-5. PubMed ID: 8439681
[TBL] [Abstract][Full Text] [Related]
9. Relationship of posttransplantation erythrocytosis to hypercalcemia in renal transplant recipients.
Akcay A; Kanbay M; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3103-5. PubMed ID: 16213320
[TBL] [Abstract][Full Text] [Related]
10. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
Ahmed S; Ahmed E; Naqvi R; Qureshi S
J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
[TBL] [Abstract][Full Text] [Related]
12. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
[TBL] [Abstract][Full Text] [Related]
14. Factors inducing posttransplant erythrocytosis.
Lezaić V; Djukanović LJ; Pavlović-Kentera V; Clemons G; Biljanović-Paunović L
Eur J Med Res; 1997 Sep; 2(9):407-12. PubMed ID: 9300939
[TBL] [Abstract][Full Text] [Related]
15. Erythrocythemia following renal transplantation: influence of diuretic therapy.
Pollak R; Maddux MS; Cohan J; Jacobsson PK; Mozes MF
Clin Nephrol; 1988 Mar; 29(3):119-23. PubMed ID: 3282731
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.
Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N
J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741
[TBL] [Abstract][Full Text] [Related]
17. Erythrocytosis after renal transplantation: risk factors and relationship with GFR.
Nankivell BJ; Allen RD; O'Connell PJ; Chapman JR
Clin Transplant; 1995 Oct; 9(5):375-82. PubMed ID: 8541630
[TBL] [Abstract][Full Text] [Related]
18. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
[TBL] [Abstract][Full Text] [Related]
19. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Gleiter CH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
[TBL] [Abstract][Full Text] [Related]
20. Iron deficiency--an underrecognized problem in nonanemic and erythrocytic kidney transplant recipients: risks and effects of ACEI and of iron treatment.
Jimeno L; Rodado R; Campos M; Lanuza M
Transplant Proc; 2005 Mar; 37(2):1007-8. PubMed ID: 15848606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]